Kedrion Biopharma’s Post

In healthcare's forefront, Preterm Birth Diagnostic Test Kits shine as crucial tools, symbolizing early risk detection and precision care. 𝑰𝒏𝒒𝒖𝒊𝒓𝒚 𝒇𝒐𝒓 𝒇𝒓𝒆𝒆 𝑷𝑫𝑭 𝒔𝒂𝒎𝒑𝒍𝒆: https://lnkd.in/dVFCi6QS 🌟 Their advanced technologies signify a commitment to maternal #health and neonatal well-being. These kits, integral in proactive healthcare, safeguard maternal health and ensure optimal neonatal care. Embodying progress, they play a vital role in shaping a healthier future. 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭: 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞: Fetal fibronectin test kits (fFN) Placental alpha micro-globulin-1 test kits (PAMG-1) Insulin like growth factor binding protein-1 test kits (IGFBP-1) 𝐁𝐲 𝐒𝐚𝐦𝐩𝐥𝐞 𝐓𝐲𝐩𝐞: Blood sample Urine sample Vaginal discharge sample  𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫: Hospitals Diagnostic centers Clinics Others #PretermBirth #DiagnosticKits #maternalhealth #neonatalcare #healthtech #medicalinnovation #globalhealthcare #womenhealth #healthcareinnovation #diagnostictesting

Insights into Maternal and Fetal Outcomes During COVID-19 In my ongoing journey to understand the multifaceted impacts of health crises, I recently had the opportunity to analyse retrospective data on maternal and fetal outcomes in cases of mild SARS-CoV-2 infections in pregnant women at a tertiary teaching hospital. This exercise has greatly enriched my knowledge and understanding of the nuances involved in managing health during a pandemic. Key Findings: The data revealed that most pregnant women with mild or asymptomatic COVID-19 had favourable maternal and fetal outcomes. However, it was noted that symptomatic women exhibited higher D-dimer levels and pulse rates, suggesting the necessity for careful monitoring to mitigate thrombotic risks. Conclusion: These findings underscore the importance of routine screening and the provision of personalised, tailored medical and obstetric care for pregnant women during pandemics such as COVID-19. Engaging with such data not only deepens my understanding of public health challenges but also enhances my ability to contribute meaningfully to ongoing discussions in this critical area—an advantage I value greatly. #PublicHealth #MaternalHealth #COVID19 #Research #Healthcare #MedicalEducation

Read an article: Moving towards early diagnosis I would like to express my joy over this article on newborn screening for metachromatic leukodystrophy (MLD) and the European consensus-based recommendations for clinical management. Newborn screening for MLD aligns with established criteria, offering solution for early diagnosis. These consensus-based guidelines will enhance harmonized management and support integration into national screening programs. With treatment options available, delayed diagnosis has become the major hurdle: as two-thirds of patients are diagnosed too late to be eligible to benefit from treatment. This consensus marks a significant step forward in managing MLD and ensuring early and effective treatment, and underscores the importance of a patient-centered approach in developing these recommendations. A big thank you to everyone involved! Link to the article for detailed insights and recommendations in comments... #NewbornScreening #MLD #MetachromaticLeukodystrophy #RareDiseases #EuropeanConsensus #PatientCare #GeneTheraphy #EarlyIntervention #MedicalResearch #HealthConsensus #testMLD #medasol 

🌐 Today, on International Women's Day, we honor and recognize the strength and resilience of women around the globe. At SIS Medical we are deeply committed to supporting women's health, particularly in the fight against cardiovascular disease – the No. 1 killer of women worldwide. Here's why our commitment is stronger than ever: 🔴 Facts to Ponder: - Cardiovascular disease claims the lives of 1 in 3 women each year – it's a stark reality that touches every corner of our community. - Despite the widespread impact, most cardiovascular diseases can be prevented through education and lifestyle changes. - Women of all ages are at risk, and unique factors like pregnancy and menopause can heighten this risk. Stress and the mind-body connection also play crucial roles in women's cardiovascular health. 💡 How We're Making a Difference: As a Europe-based medical device manufacturer, we're at the forefront of innovation with our OPN NC PTCA balloons, specifically designed for Percutaneous Coronary Intervention (PCI). Our OPN NC device, known for its robustness in high-pressure scenarios, is crucial for treating challenging coronary conditions, especially in women who may have unique cardiovascular needs. Peer-reviewed studies affirm the efficacy of our products in managing heavily calcified lesions, a common challenge in cardiovascular interventions, with a strong track record of safety and effectiveness. 🤝 Join Us: This International Women's Day, let's pledge to prioritize women's heart health. Together, we can make a difference in the lives of our mothers, sisters, friends, and countless women worldwide. At SIS Medical, we're committed to this fight, today and every day. #InternationalWomensDay #WomensHealth #CardiovascularDisease #MedicalDevices #HeartHealth #InnovationForHealth #IWD24

Are you familiar with NEST (Neonatal Essential Survival Technology)? The mission of the NEST Project by the Chiesi Foundation is to reduce neonatal mortality, especially among vulnerable, premature, or low birth weight infants in areas where almost everything is missing and where simple but well-prepared interventions have a significant impact. The NEST Project is making a difference for these precious lives, establishing neonatology wards equipped with resources and medical instruments, taking into account diverse health structures and resource levels.       Learn more about NEST and other Chiesi Foundation projects: https://lnkd.in/ghx9SdB3     #Chiesi_USA #CareBeyondTreatment #ThePlacetoBe

Newborn screening stands as a pivotal first step in the early identification of rare diseases before the onset of symptoms, illuminating a path of hope for timely medical interventions and enhanced health prospects. The significance of newborn screening is monumental. This simple test, conducted just days after birth, can detect conditions like phenylketonuria (PKU), cystic fibrosis, and sickle cell disease, setting the stage for early treatment and a better quality of life. Let's advocate for universal newborn screening to ensure every child has the chance to thrive. Read more about the lifesaving impact of newborn screening and how it empowers parents and healthcare professionals to secure a healthier future for our children on The Times Of India - Ms. Chandra Ganjoo, Group CEO, Trivitron Healthcare. https://lnkd.in/gsgNP-WF #NewbornScreening #NBS #EarlyDiagnosis #RareDiseases #MedicalIntervention #HealthcareAdvocacy #QualityOfLife #TimesOfIndia #TrivitronHealthcare #Trivitron

Are you familiar with NEST (Neonatal Essential Survival Technology)? The mission of the NEST Project by the Chiesi Foundation is to reduce neonatal mortality, especially among vulnerable, premature, or low birth weight infants in areas where almost everything is missing and where simple but well-prepared interventions have a significant impact. The NEST Project is making a difference for these precious lives, establishing neonatology wards equipped with resources and medical instruments, taking into account diverse health structures and resource levels.   Learn more about NEST and other Chiesi Foundation projects: https://lnkd.in/ghx9SdB3 #Chiesi_USA #ChiesithePlacetoB #BCorp #NICUAwareness 

New Born Screening: Ensuring a Healthy Start for Every Little Life As a healthcare professional dedicated to improving lives, I'm thrilled to shed light on the importance of New Born Screening. It's a vital process that involves testing newborn babies for certain genetic, metabolic, and developmental conditions shortly after birth. Here's why it matters: 1️⃣ Blood Testing: One of the cornerstone components of New Born Screening is blood testing. By analyzing a small sample of blood, healthcare providers can identify potential health issues early on, allowing for timely intervention and treatment. 2️⃣ Conditions: New Newborn screening helps detect a range of conditions that may not be apparent at birth but could cause serious health problems if left undetected. These conditions include congenital hypothyroidism, phenylketonuria (PKU), cystic fibrosis, and many others. 3️⃣ Save Lives: Perhaps the most compelling aspect of New Born Screening is its ability to save lives. By catching health issues early, healthcare professionals can initiate appropriate interventions, preventing complications and enabling babies to lead healthier, happier lives. At its core, New newborn screening is about giving every newborn the best possible start in life. It's about early detection, intervention, and ultimately, the gift of health and well-being. Let's continue to advocate for widespread access to this essential screening tool and ensure that every precious life receives the care it deserves. #NewBornScreening #Healthcare #EarlyDetection #SaveLives #AnilMakhija

Newborn screening is a cornerstone of public health, a pivotal process that identifies and addresses potential health issues in the earliest stages of an infant's life. Early detection and intervention, facilitated by cutting-edge systems, can pave the way for overcoming certain conditions, setting the foundation for a healthier start. OMNI-Lab NBS is our top-tier Newborn Critical Congenital Heart Disease system, a beacon of innovation in this critical realm and here's why: - Patient-centric database: Tailored to prioritise the unique needs of each newborn. - User-defined observation templates: Allowing healthcare professionals to customise templates according to the requirements of individual patients. - Comprehensive result organisation: A robust system for capturing and organising results and comments from healthcare professionals. - Specialised patient registration: Including specialised data fields designed specifically for newborns, ensuring attention to detail. - Streamlined information management: Effortlessly manage patient information with accession and episode registration, promoting efficiency in handling critical data. - Integration with point-of-care testing (PoCT) analysers: Seamlessly interfaces with PoCT analysers and oximeters, ensuring smooth integration of test results into the healthcare ecosystem. These features, among others, position our Newborn Critical Congenital Heart Disease software as an exceptional tool for healthcare professionals dedicated to the well-being of newborns. https://lnkd.in/dgDm9re #laboratorysoftware #laboratoryequipment #labsoftware #softwaresolutions #medicalsoftware #iss #qms #OMNILAB

Price transparency availability to both physicians and patients are a powerful tool to prevent surprise billing and allows free market solutions to site-of-service price variability through informed choice